These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27131877)

  • 21. Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity.
    Valiyaveettil M; Alamneh YA; Doctor BP; Nambiar MP
    Toxicol Lett; 2012 Apr; 210(1):87-94. PubMed ID: 22301377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
    Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
    Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates.
    Costa LG; Cole TB; Furlong CE
    J Toxicol Clin Toxicol; 2003; 41(1):37-45. PubMed ID: 12645966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and purification of biologically active recombinant human paraoxonase 1 from a Drosophila S2 stable cell line.
    Yun H; Yu J; Kim S; Lee N; Lee J; Lee S; Kim ND; Yu C; Rho J
    Protein Expr Purif; 2017 Mar; 131():34-41. PubMed ID: 27838376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of organophosphate intoxication on human serum paraoxonase.
    Sözmen EY; Mackness B; Sözmen B; Durrington P; Girgin FK; Aslan L; Mackness M
    Hum Exp Toxicol; 2002 May; 21(5):247-52. PubMed ID: 12141395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.
    Costa LG; Giordano G; Cole TB; Marsillach J; Furlong CE
    Toxicology; 2013 May; 307():115-22. PubMed ID: 22884923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes.
    Otto TC; Harsch CK; Yeung DT; Magliery TJ; Cerasoli DM; Lenz DE
    Biochemistry; 2009 Nov; 48(43):10416-22. PubMed ID: 19764813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
    Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
    J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay between amino acid residues at positions 192 and 115 in modulating hydrolytic activities of human paraoxonase 1.
    Bajaj P; Aggarwal G; Tripathy RK; Pande AH
    Biochimie; 2014 Oct; 105():202-10. PubMed ID: 25107406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum paraoxonase 1 (PON1) measurement: an update.
    Ceron JJ; Tecles F; Tvarijonaviciute A
    BMC Vet Res; 2014 Mar; 10():74. PubMed ID: 24666514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of an organophosphorus hydrolase enzyme (OpdA) in human serum and minipig models of organophosphorus insecticide poisoning.
    Eddleston M; Clutton RE; Taylor M; Thompson A; Worek F; John H; Thiermann H; Scott C
    Clin Toxicol (Phila); 2020 May; 58(5):397-405. PubMed ID: 31452424
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications.
    Ashani Y; Leader H; Aggarwal N; Silman I; Worek F; Sussman JL; Goldsmith M
    Chem Biol Interact; 2016 Nov; 259(Pt B):252-256. PubMed ID: 27163850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.
    Iyengar AR; Pande AH
    Protein J; 2016 Dec; 35(6):424-439. PubMed ID: 27830420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new post-intoxication treatment of paraoxon and parathion poisonings using an evolved PON1 variant and recombinant GOT1.
    Goldsmith M; Ashani Y; Margalit R; Nyska A; Mirelman D; Tawfik DS
    Chem Biol Interact; 2016 Nov; 259(Pt B):242-251. PubMed ID: 27256520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
    Cole TB; Jansen K; Park S; Li WF; Furlong CE; Costa LG
    Adv Exp Med Biol; 2010; 660():47-60. PubMed ID: 20221870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraoxonase activity and genetic polymorphisms in northern Han Chinese workers exposed to organophosphate pesticides.
    Zhang X; Sui H; Li H; Zheng J; Wang F; Li B; Zhang Y
    Exp Biol Med (Maywood); 2014 Feb; 239(2):232-9. PubMed ID: 24326413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering human PON1 in an E. coli expression system.
    Suzuki SM; Stevens RC; Richter RJ; Cole TB; Park S; Otto TC; Cerasoli DM; Lenz DE; Furlong CE
    Adv Exp Med Biol; 2010; 660():37-45. PubMed ID: 20221869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of highly purified human paraoxonase (PON1): association with human phosphate binding protein (HPBP) is essential for preserving its active conformation(s).
    Rochu D; Renault F; Cléry-Barraud C; Chabrière E; Masson P
    Biochim Biophys Acta; 2007 Jul; 1774(7):874-83. PubMed ID: 17556053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase 1 as a major bioactivating hydrolase for olmesartan medoxomil in human blood circulation: molecular identification and contribution to plasma metabolism.
    Ishizuka T; Fujimori I; Nishida A; Sakurai H; Yoshigae Y; Nakahara K; Kurihara A; Ikeda T; Izumi T
    Drug Metab Dispos; 2012 Feb; 40(2):374-80. PubMed ID: 22086979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.